VOYA Investment Management
ZVRA icon

VOYA Investment Management’s Zevra Therapeutics ZVRA Stock Holding History

VOYA Investment Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,334
Closed -$92.6K – 2455
2025
Q4 		$92.6K Hold
10,334
– – ﹤0.01% 2275
2025
Q3 		$98.3K Sell
10,334
-5,352
-34% -$53.7K ﹤0.01% 2304
2025
Q2 		$138K Buy
15,686
+864
+6% +$7.01K ﹤0.01% 2410
2025
Q1 		$111K Sell
14,822
-562
-4% -$4.47K ﹤0.01% 2416
2024
Q4 		$128K Buy
15,384
+385
+3% +$3.29K ﹤0.01% 2515
2024
Q3 		$104K Sell
14,999
-1,400
-9% -$9.5K ﹤0.01% 2654
2024
Q2 		$80.4K Buy
16,399
+3,526
+27% +$16.7K ﹤0.01% 2720
2024
Q1 		$74.7K Sell
12,873
-1,990
-13% -$12.2K ﹤0.01% 2676
2023
Q4 		$97.4K Hold
14,863
– – ﹤0.01% 2761
2023
Q3 		$71.6K Hold
14,863
– – ﹤0.01% 2802
2023
Q2 		$75.8K Buy
+14,863
New +$80.1K ﹤0.01% 2856
2022
Q2 		– Sell
-10,899
Closed -$55K – 2905
2022
Q1 		$55K Hold
10,899
– – ﹤0.01% 2586
2021
Q4 		$95K Sell
10,899
-594
-5% -$5.3K ﹤0.01% 2671
2021
Q3 		$107K Hold
11,493
– – ﹤0.01% 2722
2021
Q2 		$147K Buy
+11,493
New +$124K ﹤0.01% 2683

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

VOYA Investment Management's ZVRA Position: Q1 2026 in Review

VOYA Investment Management sold out of Zevra Therapeutics (ZVRA) in Q1 2026, closing a stake of 10,334 shares — an estimated $92.6K sold.

VOYA Investment Management first reported a position in ZVRA in Q2 2021 and held it in 15 quarters. The position peaked at $147K in Q2 2021. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • VOYA Investment Management reported no remaining Zevra Therapeutics position as of Q1 2026 after selling out during the quarter.
  • VOYA Investment Management sold 10,334 Zevra Therapeutics shares in Q1 2026, an estimated $92.6K.
  • VOYA Investment Management first reported a position in Zevra Therapeutics in Q2 2021 and held it in 15 quarters.
  • VOYA Investment Management's Zevra Therapeutics position peaked at $147K in Q2 2021.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.